SpringerLink
Log in

Semaglutid – neue Hoffnung bei Adipositas?

Semaglutide—New hope in obesity?

  • Pädiatrie aktuell | Für Sie gelesen
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Abteilung für Kinder und Jugendliche, Landeskrankenhaus Hochsteiermark/Leoben, Vordernbergerstr. 42, 8700, Leoben, Österreich

    Reinhold Kerbl

Authors
  1. Reinhold Kerbl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reinhold Kerbl.

Ethics declarations

Interessenkonflikt

R. Kerbl gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

Reinhold Kerbl, Leoben

Tim Niehues, Krefeld

Peter Voitl, Wien

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kerbl, R. Semaglutid – neue Hoffnung bei Adipositas?. Monatsschr Kinderheilkd 171, 197–198 (2023). https://doi.org/10.1007/s00112-023-01709-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-023-01709-7

Search

Navigation